Jesús Florián
Impact in
-
- Breast Cancer Treatment Studies
-
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
Papers in
- Oncology 9
- Cancer Treatment and Pharmacology 7
- Colorectal Cancer Treatments and Studies 2
- Lung Cancer Research Studies 1
-
- Breast Cancer Treatment Studies 3
- Co-authors
- Antonio Antón (4 shared papers)José Fortes (1 shared paper)José Manuel López-Vega (2 shared papers)Laura García‐Estévez (1 shared paper)Francisco S. N. Lobo (1 shared paper)Ana Herrero (1 shared paper)Lourdes Calvo (3 shared papers)María José Godes (2 shared papers)
- Journals
- Clinical Breast Cancer (2 papers)Breast Cancer Research and Treatment (2 papers)Journal of Clinical Oncology (2 papers)Cancer Research (2 papers)Annals of Oncology (1 paper)
- Partner nations
- SpainUnited States
In The Last Decade
Jesús Florián
14 papers receiving 196 citations
Peers
Comparison fields: 5 of 30
- Cancer Research 107
- Oncology 142
- Dermatology 11
- Pulmonary and Respiratory Medicine 25
- Pathology and Forensic Medicine 13
Countries citing papers authored by Jesús Florián
This map shows the geographic impact of Jesús Florián's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Florián with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Florián more than expected).
Fields of papers citing papers by Jesús Florián
This network shows the impact of papers produced by Jesús Florián. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Florián. The network helps show where Jesús Florián may publish in the future.
Co-authors
The 25 scholars most cited alongside Jesús Florián, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 65 | |
| 2 | Weekly docetaxel as neoadjuvant chemotherapy for stage II and III breast cancer: efficacy and correlation with biological markers in a phase II, multicenter study. | 2003 | 61 |
| 3 | 2005 | 21 | |
| 4 | 2004 | 15 | |
| 5 | 2003 | 14 | |
| 6 | 2003 | 7 | |
| 7 | 1996 | 4 | |
| 8 | 2004 | 4 | |
| 9 | 2011 | 3 | |
| 10 | 2016 | 3 | |
| 11 | 2011 | 3 | |
| 12 | 2019 | 2 | |
| 13 | 2016 | 1 | |
| 14 | 2005 | 1 | |
| 15 | 2017 | 0 |
About Jesús Florián
Jesús Florián is a scholar working on Oncology, Cancer Research, Genetics, Pulmonary and Respiratory Medicine and Surgery, having authored 15 papers that have together received 204 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (3 papers), Advanced Breast Cancer Therapies (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Colorectal Cancer Treatments and Studies (2 papers), Lung Cancer Research Studies (1 paper), Management of metastatic bone disease (1 paper) and Microtubule and mitosis dynamics (1 paper). The work is most often cited by research in Cancer Research (107 citations), Oncology (142 citations), Dermatology (11 citations), Pulmonary and Respiratory Medicine (25 citations) and Pathology and Forensic Medicine (13 citations). Jesús Florián has collaborated with scholars based in Spain and United States. Frequent co-authors include Antonio Antón, José Fortes, José Manuel López-Vega, Laura García‐Estévez, Francisco S. N. Lobo, Ana Herrero, Lourdes Calvo, María José Godes, Emilio Alba and A. Pelegrí. Their work appears in journals such as Clinical Breast Cancer, Breast Cancer Research and Treatment, Journal of Clinical Oncology, Cancer Research and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.